289 related articles for article (PubMed ID: 19691928)
1. Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.
Reiss AB
Curr Rheumatol Rep; 2009 Aug; 11(4):255-60. PubMed ID: 19691928
[TBL] [Abstract][Full Text] [Related]
2. Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases.
Wang Y; Yu H; He J
Discov Med; 2020; 30(159):49-56. PubMed ID: 33357362
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in systemic lupus erythematosus.
Szabó MZ; Szodoray P; Kiss E
Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
[TBL] [Abstract][Full Text] [Related]
4. High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.
Kim SY; Yu M; Morin EE; Kang J; Kaplan MJ; Schwendeman A
Arthritis Rheumatol; 2020 Jan; 72(1):20-30. PubMed ID: 31350818
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.
Gautier EL; Huby T; Ouzilleau B; Doucet C; Saint-Charles F; Gremy G; Chapman MJ; Lesnik P
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1625-31. PubMed ID: 17446440
[TBL] [Abstract][Full Text] [Related]
6. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.
Braun Na; Wade NS; Wakeland EK; Major AS
Lupus; 2008 Dec; 17(12):1070-8. PubMed ID: 19029274
[TBL] [Abstract][Full Text] [Related]
7. Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
Reiss AB; Anwar K; Merrill JT; Chan ES; Awadallah NW; Cronstein BN; Michael Belmont H; Belilos E; Rosenblum G; Belostocki K; Bonetti L; Hasneen K; Carsons SE
Rheumatol Int; 2010 Mar; 30(5):591-8. PubMed ID: 19547978
[TBL] [Abstract][Full Text] [Related]
8. Vaccination, atherosclerosis and systemic lupus erythematosus.
Carvalho JF; Pereira RM; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
[TBL] [Abstract][Full Text] [Related]
9. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
10. Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.
Reiss AB; Arain HA; Kasselman LJ; Renna HA; Zhen J; Voloshyna I; DeLeon J; Carsons SE; Petri M
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438615
[No Abstract] [Full Text] [Related]
11. High-density lipoprotein functionality in systemic lupus erythematosus.
Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
Hahn BH; McMahon M
Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
[TBL] [Abstract][Full Text] [Related]
13. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Hahn BH; Grossman J; Ansell BJ; Skaggs BJ; McMahon M
Arthritis Res Ther; 2008; 10(4):213. PubMed ID: 18828865
[TBL] [Abstract][Full Text] [Related]
14. Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.
Al Gadban MM; Alwan MM; Smith KJ; Hammad SM
Clin Immunol; 2015 Apr; 157(2):133-44. PubMed ID: 25638414
[TBL] [Abstract][Full Text] [Related]
15. Update on vascular disease in systemic lupus erythematosus.
Kao AH; Sabatine JM; Manzi S
Curr Opin Rheumatol; 2003 Sep; 15(5):519-27. PubMed ID: 12960475
[TBL] [Abstract][Full Text] [Related]
16. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.
Full LE; Ruisanchez C; Monaco C
Arthritis Res Ther; 2009; 11(2):217. PubMed ID: 19435478
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.
Voloshyna I; Teboul I; Littlefield MJ; Siegart NM; Turi GK; Fazzari MJ; Carsons SE; DeLeon J; Reiss AB
Exp Biol Med (Maywood); 2016 Aug; 241(14):1611-9. PubMed ID: 27190277
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
McMahon M; Hahn BH
Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
Roman MJ; Shanker BA; Davis A; Lockshin MD; Sammaritano L; Simantov R; Crow MK; Schwartz JE; Paget SA; Devereux RB; Salmon JE
N Engl J Med; 2003 Dec; 349(25):2399-406. PubMed ID: 14681505
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
